Platform adaptive trial of novel antivirals for early treatment of COVID-19 In the community (PANORAMIC): protocol for a randomised, controlled, open-label, adaptive platform trial of community novel antiviral treatment of COVID-19 in people at increased risk of more severe disease
<strong>Introduction <br></strong>There is an urgent need to determine the safety, effectiveness and cost-effectiveness of novel antiviral treatments for COVID-19 in vaccinated patients in the community at increased risk of morbidity and mortality from COVID-19. <br><stron...
Main Authors: | Gbinigie, O, Ogburn, E, Allen, J, Dorward, J, Dobson, M, Madden, T-A, Yu, L-M, Lowe, DM, Rahman, N, Petrou, S, Richards, D, Hood, K, Patel, M, Saville, BR, Marion, J, Holmes, J, Png, ME, Hayward, G, Lown, M, Harris, V, Jani, B, Hart, N, Khoo, S, Rutter, H, Chalk, J, Standing, JF, Breuer, J, Lavallee, L, Hadley, E, Cureton, L, Benysek, M, Andersson, MI, Francis, N, Thomas, NPB, Evans, P, van Hecke, O, Koshkouei, M, Coates, M, Barrett, S, Bateman, C, Davies, J, Raymundo-Wood, I, Ustianowski, A, Nguyen-Van-Tam, J, Carson-Stevens, A, Hobbs, R, Little, P, Butler, CC |
---|---|
Format: | Journal article |
Language: | English |
Published: |
BMJ Publishing Group
2023
|
Similar Items
-
Colchicine for COVID-19 in adults in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial
by: PRINCIPLE Trial Collaborative Group, et al.
Published: (2021) -
Colchicine for COVID-19 in the community (PRINCIPLE): a randomised, controlled, adaptive platform trial
by: Dorward, J, et al.
Published: (2022) -
Clinical antiviral efficacy of favipiravir in early COVID-19 (PLATCOV): an open-label, randomised, controlled, adaptive platform trial
by: Luvira, V, et al.
Published: (2024) -
Platform Randomised trial of INterventions against COVID-19 In older peoPLE (PRINCIPLE): protocol for a randomised, controlled, open-label, adaptive platform, trial of community treatment of COVID-19 syndromic illness in people at higher risk
by: Hayward, G, et al.
Published: (2021) -
Early triple antiviral therapy for COVID-19
by: Lee, N, et al.
Published: (2020)